JP2014514278A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014514278A5 JP2014514278A5 JP2013558177A JP2013558177A JP2014514278A5 JP 2014514278 A5 JP2014514278 A5 JP 2014514278A5 JP 2013558177 A JP2013558177 A JP 2013558177A JP 2013558177 A JP2013558177 A JP 2013558177A JP 2014514278 A5 JP2014514278 A5 JP 2014514278A5
- Authority
- JP
- Japan
- Prior art keywords
- biological sample
- subtype
- anthracycline
- breast cancer
- her2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161453035P | 2011-03-15 | 2011-03-15 | |
| US61/453,035 | 2011-03-15 | ||
| PCT/US2012/029226 WO2012125828A2 (en) | 2011-03-15 | 2012-03-15 | Methods of treating breast cancer with anthracycline therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016075592A Division JP2016130256A (ja) | 2011-03-15 | 2016-04-05 | アントラサイクリン療法を用いて乳癌を処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014514278A JP2014514278A (ja) | 2014-06-19 |
| JP2014514278A5 true JP2014514278A5 (enExample) | 2015-03-19 |
| JP5971769B2 JP5971769B2 (ja) | 2016-08-17 |
Family
ID=46831350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558177A Expired - Fee Related JP5971769B2 (ja) | 2011-03-15 | 2012-03-15 | アントラサイクリン療法を用いて乳癌を処置する方法 |
| JP2016075592A Pending JP2016130256A (ja) | 2011-03-15 | 2016-04-05 | アントラサイクリン療法を用いて乳癌を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016075592A Pending JP2016130256A (ja) | 2011-03-15 | 2016-04-05 | アントラサイクリン療法を用いて乳癌を処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9066963B2 (enExample) |
| EP (1) | EP2685988A4 (enExample) |
| JP (2) | JP5971769B2 (enExample) |
| AU (2) | AU2012229123B2 (enExample) |
| CA (1) | CA2830240A1 (enExample) |
| IL (1) | IL228449A (enExample) |
| WO (1) | WO2012125828A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12324657B2 (en) | 2007-11-28 | 2025-06-10 | Intervet Inc. | System and method for diagnosis of bovine diseases using auscultation analysis |
| SI2297359T1 (sl) | 2008-05-30 | 2014-05-30 | The University Of North Carolina At Chapel Hill | Profili genskega izraĹľanja za napovedovanje izida raka dojke |
| ES2562274T3 (es) | 2010-10-06 | 2016-03-03 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | Procedimiento para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de mama |
| US9517229B2 (en) | 2011-07-29 | 2016-12-13 | Medivation Prostate Therapeutics, Inc. | Treatment of breast cancer |
| WO2013082440A2 (en) | 2011-11-30 | 2013-06-06 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with taxane therapy |
| EP2650682A1 (en) | 2012-04-09 | 2013-10-16 | Fundació Privada Institut de Recerca Biomèdica | Method for the prognosis and treatment of cancer metastasis |
| BR112015018929B8 (pt) * | 2013-02-06 | 2023-01-31 | Geissler Companies Llc | Sistema de saúde eletrônico para determinar a eficácia de uma droga administrada usando análise de auscultação |
| EP3524698A1 (en) * | 2013-10-09 | 2019-08-14 | Fundació Institut de Recerca Biomèdica IRB (Barcelona) | Method for the prognosis and treatment of cancer metastasis |
| AU2015349870B2 (en) | 2014-11-21 | 2019-09-26 | Bruker Spatial Biology, Inc. | Enzyme- and amplification-free sequencing |
| ES2756399T3 (es) | 2014-11-24 | 2020-04-27 | Nanostring Technologies Inc | Métodos y aparatos para la purificación y formación de imágenes de genes |
| BR112017012142A2 (pt) | 2014-12-12 | 2018-01-02 | Medivation Prostate Therapeutics Inc | método para predição da resposta a agentes terapêuticos para o câncer de mama e método de tratamento de câncer de mama |
| CN114350752B (zh) | 2015-07-17 | 2025-02-25 | 布鲁克空间生物学公司 | 在横切面组织的用户定义区域中的基因表达的同时定量 |
| MY199595A (en) | 2016-03-02 | 2023-11-08 | Eisai R&D Man Co Ltd | Eribulin-based antibody-drug conjugates and methods of use |
| CN116200462B (zh) | 2016-05-16 | 2025-10-03 | 布鲁克空间生物学公司 | 用于检测样品中目标核酸的方法 |
| CA3025264A1 (en) | 2016-05-25 | 2017-11-30 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-maf status |
| AU2017361521B2 (en) | 2016-11-21 | 2020-08-27 | Bruker Spatial Biology, Inc. | Chemical compositions and methods of using same |
| CA3064564C (en) | 2017-06-22 | 2021-11-30 | SNBioScience Inc. | Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same |
| CA3082728A1 (en) | 2017-11-22 | 2019-05-31 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-maf status |
| KR102893736B1 (ko) | 2018-05-14 | 2025-11-28 | 브루커 스페이셜 바이올로지, 인크. | 화학 조성물 및 이의 사용 방법 |
| CN111455055B (zh) * | 2020-04-28 | 2021-11-16 | 重庆浦洛通基因医学研究院有限公司 | 一种人类tyms基因表达量检测标准对照品 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| EP0604552B1 (en) | 1991-09-18 | 1997-02-12 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
| DE69233087T2 (de) | 1991-11-22 | 2003-12-24 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verfahren zur Herstellung von Polymerarrays |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| JP2001521753A (ja) | 1997-10-31 | 2001-11-13 | アフィメトリックス インコーポレイテッド | 成人臓器及び胎児臓器中の発現プロフィール |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US20080032293A1 (en) | 2004-07-15 | 2008-02-07 | The University Of North Carolina At Chapel Hill | Housekeeping Genes And Methods For Identifying Same |
| CA2630974A1 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| CA2635215C (en) | 2005-12-23 | 2016-08-30 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
| WO2007076129A2 (en) | 2005-12-23 | 2007-07-05 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| EP2155899A2 (en) | 2007-04-10 | 2010-02-24 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| SI2297359T1 (sl) * | 2008-05-30 | 2014-05-30 | The University Of North Carolina At Chapel Hill | Profili genskega izraĹľanja za napovedovanje izida raka dojke |
| JP5836803B2 (ja) | 2008-08-14 | 2015-12-24 | ナノストリング テクノロジーズ， インコーポレイテッド | 安定したナノレポーター |
| WO2013082440A2 (en) | 2011-11-30 | 2013-06-06 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with taxane therapy |
| CA2874492C (en) | 2012-05-22 | 2021-10-19 | British Columbia Cancer Agency Branch | Nano46 genes and methods to predict breast cancer outcome |
| JP2015530072A (ja) | 2012-06-29 | 2015-10-15 | ナノストリング テクノロジーズ，インコーポレイティド | ゲムシタビン療法による乳癌の治療方法 |
-
2012
- 2012-03-15 JP JP2013558177A patent/JP5971769B2/ja not_active Expired - Fee Related
- 2012-03-15 US US13/421,367 patent/US9066963B2/en active Active
- 2012-03-15 CA CA2830240A patent/CA2830240A1/en not_active Abandoned
- 2012-03-15 WO PCT/US2012/029226 patent/WO2012125828A2/en not_active Ceased
- 2012-03-15 AU AU2012229123A patent/AU2012229123B2/en not_active Ceased
- 2012-03-15 EP EP12757489.5A patent/EP2685988A4/en not_active Withdrawn
-
2013
- 2013-09-15 IL IL228449A patent/IL228449A/en active IP Right Grant
-
2015
- 2015-05-20 US US14/717,350 patent/US20150252440A1/en not_active Abandoned
-
2016
- 2016-04-05 JP JP2016075592A patent/JP2016130256A/ja active Pending
-
2017
- 2017-04-27 AU AU2017202786A patent/AU2017202786A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL228449A (en) | Signs of Efficacy of Breast Cancer Methods with Anthracycline Therapy | |
| Singh et al. | TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy | |
| JP6912538B2 (ja) | 血中循環腫瘍細胞に関する方法およびアッセイ | |
| Raimondi et al. | Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment | |
| EP3060680B1 (en) | Methods relating to circulating tumor cell clusters and the treatment of cancer | |
| Lee et al. | The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC) | |
| JP5980685B2 (ja) | ３剤併用抗がん剤の感受性判定マーカー | |
| US10196693B2 (en) | Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer | |
| Taschner-Mandl et al. | Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence | |
| KR20140114415A (ko) | Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커 | |
| KR20170095893A (ko) | 방광암에 대한 치료, 진단, 및 예후 방법 | |
| KR20160048196A (ko) | 교모세포종의 치료를 위한 진단 방법 및 조성물 | |
| JP2018504892A5 (enExample) | ||
| US20140030257A1 (en) | Agtr1 as a marker for bevacizumab combination therapies | |
| Hughes et al. | Differential drug responses of circulating tumor cells within patient blood | |
| WO2019178226A1 (en) | Methods for monitoring treatment response and disease progression in subjects using circulating cells | |
| Lindahl et al. | Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer | |
| JP2024529385A (ja) | 循環癌関連マクロファージ様細胞（ｃａｍｌ）の変化を用いて癌治療反応を予測及び／又はモニタリングする方法 | |
| Harris et al. | Quest for the ideal cancer biomarker: an update on progress in capture and characterization of circulating tumor cells | |
| Gogas et al. | Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: a phase II trial of the Hellenic cooperative oncology group | |
| Kim et al. | Drug response of captured BT20 cells and evaluation of circulating tumor cells on a silicon nanowire platform | |
| WO2013069010A1 (en) | Methods for individually optimizing a cancer treatment | |
| Ramsdale et al. | Personalized treatment of lymphoma: promise and reality | |
| Amiral | Extra cellular vesicles in blood circulation as biomarkers and messengers of patho-hysiological activity and alterations | |
| RU2706116C1 (ru) | Способ прогнозирования течения аденокарциномы легкого |